ISB News

Nature News: ‘Medicine Gets Up Close and Personal’ – Dr. Lee Hood’s Vision for Wellness

Infographic showing types of data

"Even in its pilot phase, the project is unusually thorough. The ISB will sequence the whole genome of each participant at the outset. And in later phases, Hood says, the study team will also examine epigenetics: methylation and other modifications to DNA that can reflect environmental exposures. But that is just the tip of the data-collection iceberg." — From 'Medicine Gets Up Close and Personal' in Nature

The journal Nature pubished a news article today (online Feb. 11, 2014/print Feb. 12, 2014) about Dr. Lee Hood's vision for the 100K Wellness Project. The project will launch in March first with a 100-person study that eventually will scale to 100,000 individuals. Read the Nature article, written by W. Wayt Gibbs, at this link.

To learn more, watch a video of Dr. Lee Hood talk about his vision for the 100K Wellness Project:

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.